Glucose Sensing in the Peritoneal Space Offers Faster Kinetics Than Sensing in the Subcutaneous Space

The paramount goal in the treatment of type 1 diabetes is the maintenance of normoglycemia. Continuous glucose monitoring (CGM) technologies enable frequent sensing of glucose to inform exogenous insulin delivery timing and dosages. The most commonly available CGMs are limited by the physiology of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnett, Daniel R., Huyett, Lauren M., Zisser, Howard C., Doyle, Francis J., Mensh, Brett D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066336/
https://www.ncbi.nlm.nih.gov/pubmed/24622798
http://dx.doi.org/10.2337/db13-1649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066336/
https://www.ncbi.nlm.nih.gov/pubmed/24622798
http://dx.doi.org/10.2337/db13-1649

Ejemplares similares